Synchrony (SYF) announced a strategic partnership with Dental Intelligence, a leading patient relationship management and analytics platform used by over 9,000 dental practices. The partnership will integrate the CareCredit credit card solution directly into the platform’s comprehensive communication tools to help simplify how practices manage patient financing and drive administrative efficiency. With the integration, providers will easily be able to identify whether patients are preapproved for or have the CareCredit credit card. This solution, combined with CareCredit’s suite of offerings, will enhance the financing process throughout the care journey for everyone involved.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYF:
- Synchrony price target raised to $78 from $75 at RBC Capital
- Strong Credit Discipline and Strategic Focus Support Buy Rating for Synchrony Financial
- Mixed Signals in Synchrony Financial’s Outlook: Hold Rating Amid Growth Opportunities and Risks
- Synchrony price target lowered to $80 from $81 at Barclays
- Synchrony Financial Reports Strong Q2 2025 Earnings